Recludix Pharma Inc, based in San Diego, CA, is a pharmaceutical company dedicated to advancing scientific research and developing innovative treatments. With a strong commitment to their mission, Recludix focuses on the discovery and development of novel therapies targeting STAT3 and STAT6, two key proteins involved in various diseases.
Driven by a team of experienced leaders and supported by strategic partnerships and investors, Recludix utilizes its cutting-edge platform science programs to identify potential drug candidates for their pipeline. Through their dedication to scientific excellence, Recludix aims to make a significant impact in the field of medicine and improve patient outcomes.
Generated from the website